πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7244558

Production of novel Newcastle disease virus strains from cDNAs and improved live attenuate

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7227011

Nucleic acid vaccines for prevention of flavivirus infection

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7226602

Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223585

Viral purification methods

ONCOLYTICS BIOTECH INC. Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223844

Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus select

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223787

Prenylation inhibitors reduce host cell permissiveness to viral replication

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223388

Modified reoviral therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7220419

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7220852

Coronavirus isolated from humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7217812

Extraneous DNA sequence that facilitates hantavirus gene expression

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7217418

Multivalent dengue virus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7214524

Marek's disease virus vaccine

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7211255

Contraceptives based on SP22 and SP22 antibodies

United States of America The U.S. Environmental Protection Agency Β· Granted Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7208313

Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7208161

Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7201911

Cloned genomes of infectious hepatitis C viruses and uses thereof

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7201907

Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7198783

Sensitization of neoplastic cells to radiation therapy with reovirus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7192593

Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection an

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7189513

Human papilloma virus immunoreactive peptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7186542

Method of extracting virus from cell culture

ONCOLYTICS BIOTECH INC. Β· Granted Tue Mar 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7183095

Cell culture system for synthesis of infectious hepatitis C virus

The Regents of the University of California Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7183268

2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7163678

Reovirus for the treatment of ral-mediated cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted